These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 8480449
21. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. Steen PA, Newberg LA, Milde JH, Michenfelder JD. J Cereb Blood Flow Metab; 1984 Mar; 4(1):82-7. PubMed ID: 6693515 [Abstract] [Full Text] [Related]
22. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats. Dreier JP, Windmüller O, Petzold G, Lindauer U, Einhäupl KM, Dirnagl U. Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352 [Abstract] [Full Text] [Related]
23. Neuronal damage in rat brain and spinal cord after cardiac arrest and massive hemorrhagic shock. Kudo Y, Ohtaki H, Dohi K, Yin L, Nakamachi T, Endo S, Yofu S, Hiraizumi Y, Miyaoka H, Shioda S. Crit Care Med; 2006 Nov; 34(11):2820-6. PubMed ID: 16971856 [Abstract] [Full Text] [Related]
27. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [Abstract] [Full Text] [Related]
28. Time course of caspase activation in selectively vulnerable brain areas following global cerebral ischemia due to cardiac arrest in rats. Teschendorf P, Padosch SA, Spöhr F, Albertsmeier M, Schneider A, Vogel P, Choi YH, Böttiger BW, Popp E. Neurosci Lett; 2008 Dec 26; 448(2):194-9. PubMed ID: 18938215 [Abstract] [Full Text] [Related]
31. Effect of the calcium entry blocker nimodipine on the metabolism of nucleic acids in rat brain ischemia. Kostron H, Sperl W, Murr C, Pillwein K. Adv Neurol; 1990 Dec 26; 52():133-9. PubMed ID: 2396509 [Abstract] [Full Text] [Related]
32. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Di Mascio R, Marchioli R, Tognoni G. Clin Trials Metaanal; 1994 Apr 26; 29(1):57-79. PubMed ID: 10150186 [Abstract] [Full Text] [Related]
33. Failure of nimodipine to improve neurologic outcome after eighteen minutes of cardiac arrest in the cat. Tateishi A, Scheller MS, Drummond JC, Zornow MH, Grafe MR, Fleischer JE, Shapiro HM. Resuscitation; 1991 Apr 26; 21(2-3):191-206. PubMed ID: 1650022 [Abstract] [Full Text] [Related]
34. The effect of mannitol and nimodipine treatment in a rat model of temporary focal ischemia. Rickels E, Gaab MR, Heissler H, Dietz H. Zentralbl Neurochir; 1993 Apr 26; 54(1):3-12. PubMed ID: 8388144 [Abstract] [Full Text] [Related]
38. Retrograde cerebral perfusion of oxygenated, compacted red blood cells attenuates brain damage after hypothermia circulation arrest of rat. Su DS, Wang XR, Zheng YJ, Zhao YH, Zhang TJ. Acta Anaesthesiol Scand; 2005 Sep 26; 49(8):1172-81. PubMed ID: 16095460 [Abstract] [Full Text] [Related]
39. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Yang Y, Li Q, Shuaib A. Exp Neurol; 2000 May 26; 163(1):39-45. PubMed ID: 10785442 [Abstract] [Full Text] [Related]